Ledger.Open graph →
SEC Form D · filed August 19, 2024

Lapix Therapeutics Inc

Offering
$5.5M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Henry Mckinnell · Cambridge, MADirectorAnas Fathallah · Cambridge, MAExec · DirectorJason Norris · Cambridge, MAExec · DirectorAnthony Gibney · Cambridge, MADirectorAnthony Gibney · Cambridge, MADirectorJason Norris · Cambridge, MAExec · DirectorAnas Fathallah · Cambridge, MAExec · DirectorHenry Mckinnell · Cambridge, MADirectorChristopher Hentemann · New York, NYDirector400 Capital GP LLC · New York, NYExec · DirectorPeter Henn · Farmington Hills, MIDirectorChristian J. Rottenkolber · Farmington Hills, MIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗